The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2017

Filed:

Jul. 08, 2015
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

William Fenical, Del Mar, CA (US);

Paul Jensen, San Diego, CA (US);

Tracy Mincer, San Diego, CA (US);

Robert H. R. Feling, Wiesbaden, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/407 (2006.01); A61K 31/397 (2006.01); A61K 31/424 (2006.01); A61K 31/43 (2006.01); C07D 491/04 (2006.01); C12P 17/18 (2006.01); A61K 45/06 (2006.01); C07D 491/044 (2006.01);
U.S. Cl.
CPC ...
A61K 31/407 (2013.01); A61K 31/397 (2013.01); A61K 31/424 (2013.01); A61K 31/43 (2013.01); A61K 45/06 (2013.01); C07D 491/04 (2013.01); C07D 491/044 (2013.01); C12P 17/18 (2013.01); C12P 17/188 (2013.01);
Abstract

The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithethas been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low ICvalues, high pharmaceutical potency, and selectivity for cancer cells over fungi.


Find Patent Forward Citations

Loading…